NCT00435539 - A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions

Vitreomacular Traction

Interventions

DRUG

ocriplasmin

Intravitreal injection of ocriplasmin solution containing 75µg of ocriplasmin.

DRUG

ocriplasmin

Intravitreal injection of ocriplasmin solution containing 125µg of ocriplasmin with up to 2 additional (open label) 125µg ocriplasmin injection at 1 month interval.

DRUG

Sham Comparator

Intravitreal sham injection

Trial Locations (4)

2020

ZNA OCMW Antwerpen, Antwerp

80336

Augenklinik der Universitat Munchen, München

B-9000

University Hospital of Ghent, Ghent

Unknown

Universitaire Ziekenhuizen K.U.Leuven, Leuven